Exicure, Inc.
XCUR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001698530
No open-market purchases or sales by Exicure, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $306.0K in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Exicure, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- −1 vs. Q1 2026
- Shares held
- 147.2K
- −24.5K (−14.3%) vs. Q1 2026
- Total value
- $306.0K
- −$425.4K (−58.2%) vs. Q1 2026
- New holders
- 3
- 3 more added
- Sold out
- 4
- 4 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XCUR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $306.0K |
| Q1 2026 | 19 | $731.4K |
| Q4 2025 | 15 | $803.0K |
| Q3 2025 | 13 | $1.58M |
| Q2 2025 | 15 | $2.62M |
| Q1 2025 | 13 | $4.26M |
| Q4 2024 | 12 | $4.21M |
| Q3 2024 | 12 | $1.10M |
| Q2 2024 | 16 | $171.6K |
| Q1 2024 | 20 | $372.1K |
| Q4 2023 | 16 | $343.9K |
| Q3 2023 | 17 | $470.1K |
| Q2 2023 | 15 | $854.3K |
| Q1 2023 | 15 | $594.1K |
| Q4 2022 | 16 | $898.5K |
| Q3 2022 | 18 | $1.12M |
| Q2 2022 | 18 | $1.56M |
| Q1 2022 | 43 | $5.12M |
| Q4 2021 | 48 | $8.50M |
| Q3 2021 | 47 | $34.9M |
| Q2 2021 | 58 | $44.4M |
| Q1 2021 | 72 | $68.2M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Exicure, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 43,111 | $89.7K | 0.00% | +10,128+30.7% | Added |
| Geode Capital Management, LLC | 31,249 | $65.0K | 0.00% | −5,664−15.3% | Reduced |
| Jane Street Group, LLC | 29,535 | $61.4K | 0.00% | +29,535 | New |
| Citadel Advisors LLC | 14,919 | $31.0K | 0.00% | +14,919 | New |
| Vanguard Fiduciary Trust Co | 13,161 | $27.4K | 0.00% | 00.0% | Unchanged |
| Northwestern University | 10,430 | $21.7K | 0.03% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,074 | $8.47K | 0.00% | +3,585+733.1% | Added |
| UBS Group AG | 342 | $711 | 0.00% | −524−60.5% | Reduced |
| Morgan Stanley | 143 | $297 | 0.00% | −15−9.5% | Reduced |
| SBI Securities Co., Ltd. | 43 | $89 | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 35 | $73 | 0.00% | −9,318−99.6% | Reduced |
| Advisor Group Holdings, Inc. | 29 | $60 | 0.00% | 00.0% | Unchanged |
| Prestige Wealth Management Group LLC | 20 | $42 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 17 | $35 | 0.00% | 00.0% | Unchanged |
| Caitong International Asset Management Co., Ltd | 6 | $12 | 0.00% | +5+500.0% | Added |
| BNP Paribas Arbitrage, SA | 4 | $8 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2 | $4 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 82 | $0 | 0.00% | +82 | New |
| Carlyle Group Inc. | 0 | $0 | 0.00% | −56,328−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −10,686−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −120−100.0% | Sold out |
| Avion Wealth | 0 | $0 | 0.00% | −120−100.0% | Sold out |